Skip links

Exosome Therapy in Miami

Exosome therapy is an emerging area of regenerative medicine focused on cellular signaling, communication, and repair response. At Karli Health, patients are evaluated by a physician-led team to determine whether exosome-based regenerative options may be appropriate based on diagnosis, medical history, goals, and safety considerations.

What Are Exosomes?

Exosomes are tiny extracellular vesicles released by cells. They carry signaling molecules such as proteins, lipids, and genetic material that help cells communicate with one another. In regenerative medicine research, exosomes are studied for their role in cellular signaling, tissue repair communication, immune modulation, and recovery response.

Why Patients Are Asking About Exosome Therapy

Patients are increasingly interested in exosome therapy because it represents a newer, cell-free approach within regenerative medicine. Unlike live cell-based therapies, exosomes are not cells themselves. They are signaling vesicles that may help influence how cells communicate in response to injury, inflammation, and tissue stress.

At Karli Health, exosome therapy is discussed as part of a broader regenerative medicine evaluation, not as a one-size-fits-all treatment.

How Exosomes Differ From Cell Therapy

Exosomes are not stem cells and they are not donor cells. They are cell-derived signaling particles.

Cell-based therapies use living cells or cell-derived products. Exosome-based approaches focus on the communication signals released by cells. This distinction matters because different regenerative options may have different sourcing, processing, regulatory, safety, and clinical considerations.

Potential Regenerative Medicine Applications

Exosome therapy is being studied across multiple areas of regenerative medicine, including tissue repair signaling, inflammation response, skin quality, orthopedic injury response, and recovery support. Patient candidacy depends on the condition being evaluated, prior treatments, imaging or diagnostic findings, medical history, and physician assessment.

Conditions and Concerns Patients Commonly Ask About

Joint Pain & Arthritis

Sports Injuries

Tendon & Ligament Injuries

Back & Spine Concerns

Skin Quality & Regenerative Aesthetics

Hair Restoration Support

Recovery & Inflammation Response

Patient Eligibility

At Karli Health, eligibility is determined through a physician-led consultation that may include medical history, diagnosis, prior treatments, imaging, lab work, medication review, your goals, and risk factors.

The goal is to determine whether exosome therapy, PRP, bone marrow concentrate, umbilical cell therapy, MUSE cell therapy, hormone optimization, or another regenerative option is the best fit.

Safety, Sourcing, and Regulatory Considerations

Because exosome-based products are biologic products, safety, sourcing, screening, processing, and regulatory status matter. Karli Health evaluates regenerative medicine options carefully and discusses the risks, limitations, and available alternatives with each patient before treatment planning.

How Karli Health Evaluates Exosome Therapy

Karli Health takes a personalized, physician-led approach to regenerative medicine. Rather than recommending a single therapy for every patient, the team evaluates the underlying condition, the patient’s goals, the biology of healing, and the available regenerative options.

For some patients, PRP or bone marrow concentrate may be more appropriate. For others, donor-derived options such as umbilical cell therapy or MUSE cell therapy may be discussed. Exosome therapy may be considered a solo treatment or added to other biologics, like stem cells. This will be discussed during a full evaluation to review appropriateness, safety, and treatment goals.

FAQ

What is exosome therapy?

Considering Exosome Therapy?

Schedule a consultation with Karli Health to learn whether exosome therapy or another regenerative medicine option may be appropriate for your condition, goals, and overall health.

This site is registered on portal.liquid-themes.com as a development site. Switch to production mode to remove this warning.